Search by Drug Name or NDC
NDC 51754-6013-03 GLYRX-PF 0.2 mg/mL Details
GLYRX-PF 0.2 mg/mL
GLYRX-PF is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exela Pharma Sciences, LLC. The primary component is GLYCOPYRROLATE.
Product Information
| NDC | 51754-6013 |
|---|---|
| Product ID | 51754-6013_2ae8439a-1a05-4d94-95d5-67614cbb8be3 |
| Associated GPIs | 4910203000E516 |
| GCN Sequence Number | 082030 |
| GCN Sequence Number Description | glycopyrrolate/PF SYRINGE 0.6MG/3ML INJECTION |
| HIC3 | J2B |
| HIC3 Description | ANTICHOLINERGICS,QUATERNARY AMMONIUM |
| GCN | 49329 |
| HICL Sequence Number | 039386 |
| HICL Sequence Number Description | GLYCOPYRROLATE/PF |
| Brand/Generic | Brand |
| Proprietary Name | GLYRX-PF |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | glycopyrrolate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 0.2 |
| Active Ingredient Units | mg/mL |
| Substance Name | GLYCOPYRROLATE |
| Labeler Name | Exela Pharma Sciences, LLC |
| Pharmaceutical Class | Anticholinergic [EPC], Cholinergic Antagonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA210997 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51754-6013-03 (51754601303)
| NDC Package Code | 51754-6013-3 |
|---|---|
| Billing NDC | 51754601303 |
| Package | 10 SYRINGE, PLASTIC in 1 CARTON (51754-6013-3) / 3 mL in 1 SYRINGE, PLASTIC |
| Marketing Start Date | 2020-12-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |